| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.15 | 0.001 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.002 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.002 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.095 | 0.003 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.003 |